29
Participants
Start Date
May 24, 2017
Primary Completion Date
April 15, 2020
Study Completion Date
April 15, 2020
Sodium Thiosulfate
Intravenous Sodium Thiosulfate Injection (25 grams sodium thiosulfate) to be administered each hemodialysis session (3 times weekly) for 3 weeks
Placebo-Normal Saline
Placebo: to be administered each hemodialysis session (3 times weekly) for 3 weeks
The Icahn School of Medicine at Mount Sinai Hospital, New York
Veterans Administration Medical Center, Albany
University of Virginia Health System, Charlottesville
Veterans Administration Medical Center, Salem
Mayo Clinic, Jacksonville
Cleveland Clinic, Cleveland
University of Iowa Hospitals and Clinics, Iowa City
Sanford Health, Fargo
Loyola University Medical Center, Maywood
Northwestern University Hospital, Chicago
Massachusetts General Hospital, Boston
Rhode Island Hospital, Providence
University of Calgary Foothills Medical Center, Calgary
University of Alberta Hospital, Edmonton
Health Sciences Centre Winnipeg, Winnipeg
Kingston Health Sciences Centre, Kingston
Centre Hospitalier de l'Universite de Montreal, Montreal
Salford Royal Hospital NHS Foundation Trust, Salford
Hammersmith Hospital, London
Churchill Hospital, Oxford
Lister Hospital, Stevenage
Lead Sponsor
Hope Pharmaceuticals
INDUSTRY